Qiagen Stock Price, News & Analysis (NASDAQ:QGEN)

$31.67 0.41 (1.31 %)
(As of 12/13/2017 11:55 AM ET)
Previous Close$31.26
Today's Range$31.32 - $31.73
52-Week Range$27.51 - $36.34
Volume753,800 shs
Average Volume956,815 shs
Market Capitalization$7.12 billion
P/E Ratio25.42
Dividend YieldN/A
Beta1.1

About Qiagen (NASDAQ:QGEN)

Qiagen logoQIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Receive QGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNASDAQ:QGEN
CUSIPN7248210
Phone31-77-355-6600

Debt

Debt-to-Equity Ratio0.68%
Current Ratio5.33%
Quick Ratio4.78%

Price-To-Earnings

Trailing P/E Ratio25.42
Forward P/E Ratio25.34
P/E Growth1.91

Sales & Book Value

Annual Sales$1.34 billion
Price / Sales5.39
Cash Flow$2.19 per share
Price / Cash14.47
Book Value$11.30 per share
Price / Book2.80

Profitability

Trailing EPS$0.39
Net Income$80.40 million
Net Margins6.40%
Return on Equity11.36%
Return on Assets6.37%

Miscellaneous

Employees4,684
Outstanding Shares227,660,000

Qiagen (NASDAQ:QGEN) Frequently Asked Questions

What is Qiagen's stock symbol?

Qiagen trades on the NASDAQ under the ticker symbol "QGEN."

How were Qiagen's earnings last quarter?

Qiagen NV (NASDAQ:QGEN) released its earnings results on Monday, November, 6th. The company reported $0.32 earnings per share for the quarter, hitting analysts' consensus estimates of $0.32. The company earned $364 million during the quarter, compared to the consensus estimate of $363.42 million. Qiagen had a return on equity of 11.36% and a net margin of 6.40%. The firm's quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.29 earnings per share. View Qiagen's Earnings History.

When will Qiagen make its next earnings announcement?

Qiagen is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for Qiagen.

What guidance has Qiagen issued on next quarter's earnings?

Qiagen updated its fourth quarter earnings guidance on Monday, November, 6th. The company provided EPS guidance of $0.41-0.42 for the period, compared to the Thomson Reuters consensus estimate of $0.41.

Where is Qiagen's stock going? Where will Qiagen's stock price be in 2017?

12 analysts have issued 12 month target prices for Qiagen's shares. Their forecasts range from $28.00 to $37.00. On average, they expect Qiagen's stock price to reach $33.36 in the next year. View Analyst Ratings for Qiagen.

Are investors shorting Qiagen?

Qiagen saw a decrease in short interest in the month of October. As of October 31st, there was short interest totalling 3,215,255 shares, a decrease of 34.9% from the October 13th total of 4,938,525 shares. Based on an average daily volume of 1,090,373 shares, the short-interest ratio is presently 2.9 days. Approximately 1.5% of the shares of the stock are short sold.

Who are some of Qiagen's key competitors?

Who are Qiagen's key executives?

Qiagen's management team includes the folowing people:

  • Manfred E. Karobath, Chairman of the Supervisory Board (Age 76)
  • Peer M. Schatz, Chief Executive Officer, Managing Director
  • Roland Sackers, Chief Financial Officer
  • Thomas Schweins, Senior Vice President - Human Resources, Strategy & Marketing Services
  • Thierry Bernard, Senior Vice President - Molecular Diagnostics Business Area
  • Laura Furmanski, Senior Vice President - Bioinformatics Business Area
  • Douglas Liu, Senior Vice President - Global Operations
  • Manuel O. Mendez, Senior Vice President - Global Commercial Operations
  • Stephane Bancel, Independent Supervisory Director (Age 44)
  • Hakan Bjorklund, Supervisory Board Director (Age 61)

Who owns Qiagen stock?

Qiagen's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Hardman Johnston Global Advisors LLC (1.58%), Manning & Napier Advisors LLC (1.21%), Frontier Capital Management Co. LLC (1.12%), Legal & General Group Plc (0.84%), First Trust Advisors LP (0.59%) and Neuberger Berman Group LLC (0.58%). View Institutional Ownership Trends for Qiagen.

Who sold Qiagen stock? Who is selling Qiagen stock?

Qiagen's stock was sold by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Manning & Napier Advisors LLC, Citadel Advisors LLC, Canada Pension Plan Investment Board, Cornerstone Capital Management Holdings LLC., California State Teachers Retirement System, AMP Capital Investors Ltd and Platinum Investment Management Ltd.. View Insider Buying and Selling for Qiagen.

Who bought Qiagen stock? Who is buying Qiagen stock?

Qiagen's stock was purchased by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, Russell Investments Group Ltd., Assenagon Asset Management S.A., First Trust Advisors LP, Fisher Asset Management LLC, Vident Investment Advisory LLC, Myriad Asset Management Ltd. and Los Angeles Capital Management & Equity Research Inc.. View Insider Buying and Selling for Qiagen.

How do I buy Qiagen stock?

Shares of Qiagen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Qiagen's stock price today?

One share of Qiagen stock can currently be purchased for approximately $31.67.

How big of a company is Qiagen?

Qiagen has a market capitalization of $7.12 billion and generates $1.34 billion in revenue each year. The company earns $80.40 million in net income (profit) each year or $0.39 on an earnings per share basis. Qiagen employs 4,684 workers across the globe.

How can I contact Qiagen?

Qiagen's mailing address is HULSTERWEG 82, VENLO P7, 5912 PL. The company can be reached via phone at 31-77-355-6600 or via email at [email protected]


MarketBeat Community Rating for Qiagen (QGEN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  249 (Vote Outperform)
Underperform Votes:  353 (Vote Underperform)
Total Votes:  602
MarketBeat's community ratings are surveys of what our community members think about Qiagen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Qiagen (NASDAQ:QGEN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.362.362.332.42
Ratings Breakdown: 0 Sell Rating(s)
9 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $30.85$30.85$30.32$27.35
Price Target Upside: 1.31% downside1.19% downside3.87% downside19.96% downside

Qiagen (NASDAQ:QGEN) Consensus Price Target History

Price Target History for Qiagen (NASDAQ:QGEN)

Qiagen (NASDAQ:QGEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2017CommerzbankReiterated RatingBuyLowView Rating Details
12/1/2017Deutsche BankReiterated RatingBuyLowView Rating Details
11/7/2017J P Morgan Chase & CoReiterated RatingNeutralN/AView Rating Details
11/3/2017CowenReiterated RatingHold$33.00N/AView Rating Details
8/28/2017DZ BankReiterated RatingNeutralLowView Rating Details
8/1/2017Independent ResearchUpgradeSell -> HoldLowView Rating Details
7/31/2017Jefferies GroupReiterated RatingHold$25.00 -> $28.00LowView Rating Details
7/21/2017Bank of AmericaReiterated RatingNeutral$33.00 -> $36.00LowView Rating Details
7/17/2017BarclaysReiterated RatingOverweight$33.00 -> $37.00LowView Rating Details
7/13/2017Wells Fargo & CompanyReiterated RatingMarket Perform$28.00 -> $31.00LowView Rating Details
7/10/2017Morgan StanleyReiterated RatingOverweight$36.00 -> $37.00LowView Rating Details
5/4/2017Evercore ISIBoost Price TargetOutperform$30.00 -> $31.50HighView Rating Details
8/1/2016MizuhoBoost Price TargetNeutral$22.00 -> $25.00N/AView Rating Details
7/25/2016Piper Jaffray CompaniesReiterated RatingNeutral$23.00N/AView Rating Details
3/15/2016CitigroupLower Price TargetNeutral$28.00 -> $25.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Qiagen (NASDAQ:QGEN) Earnings History and Estimates Chart

Earnings by Quarter for Qiagen (NASDAQ:QGEN)

Qiagen (NASDAQ QGEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2018N/AView Earnings Details
11/6/2017Q3$0.32$0.32$363.42 million$364.00 millionViewN/AView Earnings Details
7/27/20176/30/2017$0.28$0.30$353.09 million$349.00 millionViewN/AView Earnings Details
2/1/2017Q416$0.34$0.39$372.70 million$366.50 millionViewListenView Earnings Details
11/2/2016Q316$0.28$0.29$335.46 million$338.70 millionViewN/AView Earnings Details
7/28/2016Q216$0.23$0.24$326.73 million$334.40 millionViewN/AView Earnings Details
4/27/2016Q116$0.19$0.19$295.76 million$298.40 millionViewN/AView Earnings Details
2/2/2016Q415$0.32$0.33$354.47 million$349.00 millionViewN/AView Earnings Details
10/28/2015Q315$0.28$0.27$323.50 million$314.60 millionViewListenView Earnings Details
7/29/2015Q215$0.25$0.26$319.43 million$319.50 millionViewListenView Earnings Details
5/7/2015Q115$0.22$0.22$304.60 million$298.70 millionViewN/AView Earnings Details
1/28/2015Q414$0.30$0.25$367.82 million$360.80 millionViewN/AView Earnings Details
10/29/2014Q3$0.27$0.27$337.00 million$336.80 millionViewN/AView Earnings Details
7/29/2014Q214$0.25$0.26$330.76 million$331.20 millionViewN/AView Earnings Details
5/7/2014Q114$0.22$0.22$317.09 million$317.40 millionViewN/AView Earnings Details
1/29/2014Q413$0.34$0.36$365.52 million$362.60 millionViewN/AView Earnings Details
10/29/2013Q313$0.25$0.28$320.37 million$323.80 millionViewN/AView Earnings Details
7/30/2013Q213$0.24$0.27$311.75 million$316.40 millionViewN/AView Earnings Details
4/29/2013Q113$0.23$0.23$305.50 million$303.60 millionViewN/AView Earnings Details
1/29/2013Q412$0.31$0.34$327.80 million$346.50 millionViewN/AView Earnings Details
11/5/2012Q312$0.24$0.26$303.79 million$304.30 millionViewN/AView Earnings Details
7/24/2012$0.25$0.25ViewN/AView Earnings Details
4/25/2012$0.21$0.23ViewN/AView Earnings Details
1/31/2012$0.28$0.31ViewN/AView Earnings Details
11/2/2011$0.22$0.24ViewN/AView Earnings Details
7/25/2011$0.23$0.23ViewN/AView Earnings Details
4/27/2011$0.21$0.21ViewN/AView Earnings Details
1/31/2011$0.25$0.26ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Qiagen (NASDAQ:QGEN) Earnings Estimates

2017 EPS Consensus Estimate: $1.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.18$0.18$0.18
Q2 20171$0.29$0.29$0.29
Q3 20171$0.31$0.31$0.31
Q4 20171$0.42$0.42$0.42
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Qiagen (NASDAQ:QGEN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Qiagen (NASDAQ QGEN)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Qiagen (NASDAQ QGEN) News Headlines

Source:
DateHeadline
Commerzbank Reiterates Buy Rating for Qiagen (QGEN)Commerzbank Reiterates Buy Rating for Qiagen (QGEN)
www.americanbankingnews.com - December 12 at 10:50 AM
Qiagen (QGEN) Lowered to Sell at Zacks Investment ResearchQiagen (QGEN) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - December 11 at 9:52 AM
QIAGEN to Transfer U.S. Listing of Global Shares to NYSEQIAGEN to Transfer U.S. Listing of Global Shares to NYSE
finance.yahoo.com - December 9 at 7:49 AM
 Brokerages Expect Qiagen N.V. (QGEN) Will Announce Quarterly Sales of $392.98 Million Brokerages Expect Qiagen N.V. (QGEN) Will Announce Quarterly Sales of $392.98 Million
www.americanbankingnews.com - December 7 at 4:54 AM
Head to Head Analysis: Qiagen (QGEN) and PRA Health Sciences (PRAH)Head to Head Analysis: Qiagen (QGEN) and PRA Health Sciences (PRAH)
www.americanbankingnews.com - December 4 at 5:10 AM
Qiagens (QGEN) Buy Rating Reaffirmed at Deutsche BankQiagen's (QGEN) Buy Rating Reaffirmed at Deutsche Bank
www.americanbankingnews.com - December 1 at 6:11 AM
Biomillenia Leverages QIAGEN Bioinformatics in Microbiome-on-a ... - Business Wire (press release)Biomillenia Leverages QIAGEN Bioinformatics in Microbiome-on-a ... - Business Wire (press release)
www.businesswire.com - November 28 at 3:22 PM
U.K. Seeks to Take Sting Out of Brexit With Industrial StrategyU.K. Seeks to Take Sting Out of Brexit With Industrial Strategy
finance.yahoo.com - November 27 at 4:27 PM
As Brexit looms, UK pitches new industry plan, wins support from Merck, QiagenAs Brexit looms, UK pitches new industry plan, wins support from Merck, Qiagen
finance.yahoo.com - November 27 at 4:27 PM
Qiagen N.V. (QGEN) Given Consensus Recommendation of "Hold" by AnalystsQiagen N.V. (QGEN) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - November 26 at 7:46 AM
Vapid Quant Score Hurt Qiagen NV (QGEN) Rating - Investorplace.comVapid Quant Score Hurt Qiagen NV (QGEN) Rating - Investorplace.com
investorplace.com - November 24 at 9:00 AM
Head to Head Contrast: Ohr Pharmaceuticals (OHRP) vs. Qiagen N.V. (QGEN)Head to Head Contrast: Ohr Pharmaceuticals (OHRP) vs. Qiagen N.V. (QGEN)
www.americanbankingnews.com - November 23 at 3:12 AM
$392.98 Million in Sales Expected for Qiagen N.V. (QGEN) This Quarter$392.98 Million in Sales Expected for Qiagen N.V. (QGEN) This Quarter
www.americanbankingnews.com - November 19 at 2:54 PM
QIAGEN Advances Precision Medicine by Automating Guidelines on Cancer Variants in Industry-leading QIAGEN Clinical Insight SoftwareQIAGEN Advances Precision Medicine by Automating Guidelines on Cancer Variants in Industry-leading QIAGEN Clinical Insight Software
finance.yahoo.com - November 18 at 11:09 AM
 Brokerages Anticipate Qiagen N.V. (QGEN) to Post $0.41 Earnings Per Share Brokerages Anticipate Qiagen N.V. (QGEN) to Post $0.41 Earnings Per Share
www.americanbankingnews.com - November 17 at 11:20 PM
QIAGENs GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in OncologyQIAGEN's GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology
finance.yahoo.com - November 15 at 7:48 AM
QIAGEN Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphonyQIAGEN Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony
finance.yahoo.com - November 14 at 7:05 AM
Qiagen N.V. (QGEN) Short Interest UpdateQiagen N.V. (QGEN) Short Interest Update
www.americanbankingnews.com - November 14 at 2:56 AM
Zacks Investment Research Downgrades Qiagen N.V. (QGEN) to SellZacks Investment Research Downgrades Qiagen N.V. (QGEN) to Sell
www.americanbankingnews.com - November 9 at 1:00 PM
Edited Transcript of QGEN earnings conference call or presentation 7-Nov-17 2:00pm GMTEdited Transcript of QGEN earnings conference call or presentation 7-Nov-17 2:00pm GMT
finance.yahoo.com - November 9 at 12:08 PM
FY2017 Earnings Estimate for Qiagen N.V. Issued By William Blair (QGEN)FY2017 Earnings Estimate for Qiagen N.V. Issued By William Blair (QGEN)
www.americanbankingnews.com - November 9 at 7:21 AM
QIAGEN Reaffirms 2017 Adj. EPS Target - Quick FactsQIAGEN Reaffirms 2017 Adj. EPS Target - Quick Facts
www.nasdaq.com - November 7 at 9:19 AM
QIAGEN Reports Results for Third Quarter and First Nine Months of 2017QIAGEN Reports Results for Third Quarter and First Nine Months of 2017
finance.yahoo.com - November 7 at 9:19 AM
Qiagen meets 3Q profit forecastsQiagen meets 3Q profit forecasts
finance.yahoo.com - November 7 at 9:19 AM
QIAGEN (QGEN) Meets Q3 Earnings, Lags Revenues, Keeps ViewQIAGEN (QGEN) Meets Q3 Earnings, Lags Revenues, Keeps View
finance.yahoo.com - November 7 at 9:19 AM
Qiagen N.V. (QGEN) Announces Quarterly  Earnings ResultsQiagen N.V. (QGEN) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 6 at 10:50 PM
Qiagen N.V. (QGEN) Updates Q4 Earnings GuidanceQiagen N.V. (QGEN) Updates Q4 Earnings Guidance
www.americanbankingnews.com - November 6 at 5:26 PM
Should You Sell QIAGEN (QGEN) Before Earnings? - NasdaqShould You Sell QIAGEN (QGEN) Before Earnings? - Nasdaq
www.nasdaq.com - November 4 at 10:11 AM
Robust Quant Score Keeps Qiagen NV (QGEN) a Buy - Investorplace.comRobust Quant Score Keeps Qiagen NV (QGEN) a Buy - Investorplace.com
investorplace.com - November 4 at 10:11 AM
Should You Sell QIAGEN (QGEN) Before Earnings?Should You Sell QIAGEN (QGEN) Before Earnings?
finance.yahoo.com - November 4 at 10:10 AM
Qiagen N.V. (QGEN) Stock Rating Reaffirmed by Cowen and CompanyQiagen N.V. (QGEN) Stock Rating Reaffirmed by Cowen and Company
www.americanbankingnews.com - November 3 at 7:50 PM
Qiagen N.V. (QGEN) Given Consensus Recommendation of "Hold" by BrokeragesQiagen N.V. (QGEN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 1 at 10:25 AM
Qiagen Shows Improved Relative Price Performance; Still Shy Of BenchmarkQiagen Shows Improved Relative Price Performance; Still Shy Of Benchmark
finance.yahoo.com - October 31 at 8:21 AM
Qiagen N.V. (QGEN) to Release Quarterly Earnings on MondayQiagen N.V. (QGEN) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - October 30 at 5:46 AM
Qiagen N.V. (QGEN) Expected to Post Earnings of $0.32 Per ShareQiagen N.V. (QGEN) Expected to Post Earnings of $0.32 Per Share
www.americanbankingnews.com - October 28 at 3:30 AM
Healthy Earnings Momentum Keeps Qiagen NV (QGEN) a Buy - Investorplace.comHealthy Earnings Momentum Keeps Qiagen NV (QGEN) a Buy - Investorplace.com
investorplace.com - October 27 at 12:32 PM
Qiagen Shows Improved Relative Strength; Still Shy Of BenchmarkQiagen Shows Improved Relative Strength; Still Shy Of Benchmark
finance.yahoo.com - October 27 at 12:31 PM
QIAGEN and ICMP Launch Next-Generation DNA Testing Solutions for Identifying Missing PersonsQIAGEN and ICMP Launch Next-Generation DNA Testing Solutions for Identifying Missing Persons
finance.yahoo.com - October 25 at 9:36 AM
Analytics for Quant Score Drive Upgrade of Qiagen NV (QGEN) to Buy - Investorplace.comAnalytics for Quant Score Drive Upgrade of Qiagen NV (QGEN) to Buy - Investorplace.com
investorplace.com - October 21 at 8:30 AM
QIAGEN Announces High Accuracy of Bioinformatics Solutions in Womens Health Genetic ScreeningQIAGEN Announces High Accuracy of Bioinformatics Solutions in Women's Health Genetic Screening
finance.yahoo.com - October 19 at 8:25 PM
QIAGEN N.V. to Report Third Quarter and First Nine Months of 2017 ResultsQIAGEN N.V. to Report Third Quarter and First Nine Months of 2017 Results
finance.yahoo.com - October 17 at 6:33 AM
Zacks Investment Research Lowers Qiagen N.V. (QGEN) to HoldZacks Investment Research Lowers Qiagen N.V. (QGEN) to Hold
www.americanbankingnews.com - October 16 at 2:56 PM
QIAGEN Bioinformatics and NGS Solutions Enable Genomic BreakthroughsQIAGEN Bioinformatics and NGS Solutions Enable Genomic Breakthroughs
finance.yahoo.com - October 13 at 8:27 AM
Qiagen Trying To Close In On Key Technical BenchmarkQiagen Trying To Close In On Key Technical Benchmark
finance.yahoo.com - October 12 at 8:42 AM
Reviewing Qiagen N.V. (QGEN) & Celyad SA (CYAD)Reviewing Qiagen N.V. (QGEN) & Celyad SA (CYAD)
www.americanbankingnews.com - October 12 at 8:12 AM
Qiagen N.V. (QGEN) Upgraded to Buy by Zacks Investment ResearchQiagen N.V. (QGEN) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - October 10 at 3:50 PM
ETFs with exposure to QIAGEN NV : October 9, 2017ETFs with exposure to QIAGEN NV : October 9, 2017
finance.yahoo.com - October 10 at 5:40 AM
QIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic DiseasesQIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic Diseases
finance.yahoo.com - October 10 at 5:40 AM
Qiagen N.V. (QGEN) Expected to Announce Earnings of $0.32 Per ShareQiagen N.V. (QGEN) Expected to Announce Earnings of $0.32 Per Share
www.americanbankingnews.com - October 8 at 10:32 PM
QIAGENs QFT-Plus Launch to Boost Molecular Diagnostics ArmQIAGEN's QFT-Plus Launch to Boost Molecular Diagnostics Arm
finance.yahoo.com - October 8 at 8:10 PM

SEC Filings

Qiagen (NASDAQ:QGEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Qiagen (NASDAQ:QGEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Qiagen (NASDAQ QGEN) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.